anonymous
Guest
anonymous
Guest
With the recent news about the delay of the Uzedy launch and the opportunity to have additional resources placed on Austedo until decisions are made about Uzedy, why don't we just quit with all the internal banter on what could be a great opportunity for a few months. Why would we not want more voice and activity right now about our product with all the efficacy advantages it has over Ingrezza?
You all do realize that most of the negativity and doomsday hits to the Teva CF page is being posted from the competition, right? Look at all the posts over the last few months and you will see the drama they have stirred up, especially in light of so many of our old colleagues who left to go there.
If you're not happy here or don't trust the process, or even worse, think that having additional Austedo voice will hurt your territory business, then start looking elsewhere. I'm sure there are plenty of other companies out there where you'll find the perfect fit. This is pharma folks, change is inevitable.
You all do realize that most of the negativity and doomsday hits to the Teva CF page is being posted from the competition, right? Look at all the posts over the last few months and you will see the drama they have stirred up, especially in light of so many of our old colleagues who left to go there.
If you're not happy here or don't trust the process, or even worse, think that having additional Austedo voice will hurt your territory business, then start looking elsewhere. I'm sure there are plenty of other companies out there where you'll find the perfect fit. This is pharma folks, change is inevitable.